Antilymphoma Treatments Given Subsequent to Yttrium 90 Ibritumomab Tiuxetan Are Feasible in Patients with Progressive Non-Hodgkin's Lymphoma: A Review of the Literature
2004 ◽
Vol 5
(3)
◽
pp. 202-204
◽
Stephen M. Ansell
◽
Russell J. Schilder
◽
Peter C. Pieslor
◽
Leo I. Gordon
◽
Christos Emmanouilides
◽
...